Patent ID: 8779092
Filing Date: 2014-07-15
Classification: A61K,A61P

Abstract:
1. A peptide capable of selectively binding to metastatic cells having the sequence motif LRS, a length of 6 to 100 amino acids and comprising an amino acid sequence selected from the group consisting of: ARPGLRS (SEQ ID NO. 1), MRYALRS (SEQ ID NO. 2), LRPGLRS (SEQ ID NO. 3), GIYRLRS (SEQ ID NO. 6), GVYSLRS (SEQ ID NO. 7), SWYTLRS (SEQ ID NO. 111), LAYRLRS (SEQ ID NO. 113), LTYRLRS (SEQ ID NO. 115), and VRPGLRS (SEQ ID NO. 117).